181 related articles for article (PubMed ID: 34291565)
1. Elabela gene therapy promotes angiogenesis after myocardial infarction.
Jin L; Pan Y; Li Q; Li J; Wang Z
J Cell Mol Med; 2021 Sep; 25(17):8537-8545. PubMed ID: 34291565
[TBL] [Abstract][Full Text] [Related]
2. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage.
Sato T; Sato C; Kadowaki A; Watanabe H; Ho L; Ishida J; Yamaguchi T; Kimura A; Fukamizu A; Penninger JM; Reversade B; Ito H; Imai Y; Kuba K
Cardiovasc Res; 2017 Jun; 113(7):760-769. PubMed ID: 28371822
[TBL] [Abstract][Full Text] [Related]
3. Elabela-apelin receptor signaling pathway is functional in mammalian systems.
Wang Z; Yu D; Wang M; Wang Q; Kouznetsova J; Yang R; Qian K; Wu W; Shuldiner A; Sztalryd C; Zou M; Zheng W; Gong DW
Sci Rep; 2015 Feb; 5():8170. PubMed ID: 25639753
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice.
Fujii H; Sun Z; Li SH; Wu J; Fazel S; Weisel RD; Rakowski H; Lindner J; Li RK
JACC Cardiovasc Imaging; 2009 Jul; 2(7):869-79. PubMed ID: 19608138
[TBL] [Abstract][Full Text] [Related]
5. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Fc-Elabela fusion protein has extended plasma half-life andmitigates post-infarct heart dysfunction in rats.
Xi Y; Yu D; Yang R; Zhao Q; Wang J; Zhang H; Qian K; Shi Z; Wang W; Brown R; Li Y; Tian Z; Gong DW
Int J Cardiol; 2019 Oct; 292():180-187. PubMed ID: 31101543
[TBL] [Abstract][Full Text] [Related]
7. Chinese medicine GeGen-DanShen extract protects from myocardial ischemic injury through promoting angiogenesis via up-regulation of VEGF/VEGFR2 signaling pathway.
Zhai S; Zhang XF; Lu F; Chen WG; He X; Zhang CF; Wang CZ; Yuan CS
J Ethnopharmacol; 2021 Mar; 267():113475. PubMed ID: 33068653
[TBL] [Abstract][Full Text] [Related]
8. Sustained ELABELA Gene Therapy in High-salt Diet-induced Hypertensive Rats.
Schreiber CA; Holditch SJ; Generous A; Ikeda Y
Curr Gene Ther; 2017; 16(5):349-360. PubMed ID: 27903222
[TBL] [Abstract][Full Text] [Related]
9. Myocardial injection of apelin-overexpressing bone marrow cells improves cardiac repair via upregulation of Sirt3 after myocardial infarction.
Li L; Zeng H; Hou X; He X; Chen JX
PLoS One; 2013; 8(9):e71041. PubMed ID: 24039710
[TBL] [Abstract][Full Text] [Related]
10. Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction.
Li L; Zeng H; Chen JX
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H605-18. PubMed ID: 22752632
[TBL] [Abstract][Full Text] [Related]
11. Gene Therapy With Angiotensin-(1-9) Preserves Left Ventricular Systolic Function After Myocardial Infarction.
Fattah C; Nather K; McCarroll CS; Hortigon-Vinagre MP; Zamora V; Flores-Munoz M; McArthur L; Zentilin L; Giacca M; Touyz RM; Smith GL; Loughrey CM; Nicklin SA
J Am Coll Cardiol; 2016 Dec; 68(24):2652-2666. PubMed ID: 27978950
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-Inducible Factor 1 alpha (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Pathway Participates in Angiogenesis of Myocardial Infarction in Muscone-Treated Mice: Preliminary Study.
Du Y; Ge Y; Xu Z; Aa N; Gu X; Meng H; Lin Z; Zhu D; Shi J; Zhuang R; Wu X; Wang X; Yang Z
Med Sci Monit; 2018 Dec; 24():8870-8877. PubMed ID: 30531686
[TBL] [Abstract][Full Text] [Related]
13. ELABELA-APJ-Akt/YAP Signaling Axis: A Novel Mechanism of Aerobic Exercise in Cardioprotection of Myocardial Infarction Rats.
Xi Y; Li Y; Ren W; Bo W; Ma Y; Pan S; Gong DW; Tian Z
Med Sci Sports Exerc; 2023 Jul; 55(7):1172-1183. PubMed ID: 36878020
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cells overexpressing IL-8 receptor reduce cardiac remodeling and dysfunction following myocardial infarction.
Zhao X; Zhang W; Xing D; Li P; Fu J; Gong K; Hage FG; Oparil S; Chen YF
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H590-8. PubMed ID: 23771691
[TBL] [Abstract][Full Text] [Related]
15. The Elabela-APJ axis: a promising therapeutic target for heart failure.
Ma Z; Song JJ; Martin S; Yang XC; Zhong JC
Heart Fail Rev; 2021 Sep; 26(5):1249-1258. PubMed ID: 32314083
[TBL] [Abstract][Full Text] [Related]
16. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction.
Hu CH; Wu GF; Wang XQ; Yang YH; Du ZM; He XH; Xiang P
Chin Med J (Engl); 2006 Sep; 119(18):1499-506. PubMed ID: 16996002
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of apelin and Elabela in cardiovascular disease.
Gao S; Chen H
Biomed Pharmacother; 2023 Oct; 166():115268. PubMed ID: 37562237
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective effects of adipokine apelin on myocardial infarction.
Zhang BH; Guo CX; Wang HX; Lu LQ; Wang YJ; Zhang LK; Du FH; Zeng XJ
Heart Vessels; 2014 Sep; 29(5):679-89. PubMed ID: 24141989
[TBL] [Abstract][Full Text] [Related]
19. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
Azizi Y; Faghihi M; Imani A; Roghani M; Zekri A; Mobasheri MB; Rastgar T; Moghimian M
Eur J Pharmacol; 2015 Aug; 761():101-8. PubMed ID: 25936512
[TBL] [Abstract][Full Text] [Related]
20. Apelin/Elabela-APJ: a novel therapeutic target in the cardiovascular system.
Liu W; Yan J; Pan W; Tang M
Ann Transl Med; 2020 Mar; 8(5):243. PubMed ID: 32309390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
